Monday, November 16, 2026
RSS

Pharmaceutical

MiniMed Stock Gains as FDA Clearance Puts Tubeless Pump in the Spotlight

MiniMed stock gained after FDA clearance of its tubeless insulin pump, giving the $5.29 billion company a potential near-term catalyst.

November 16, 2026
Pharmaceutical

Summit Therapeutics Plunges After FDA Rejects Ivonescimab Lung Cancer Application

Summit Therapeutics shares fell 19% to 20% in premarket trading after the FDA rejected ivonescimab over insufficient overall survival benefit.

Nov 16
Pharmaceutical

Novo Nordisk’s Wegovy Pediatric Trial Points to Potential New Obesity Market

Novo Nordisk’s pediatric Wegovy trial could broaden its obesity franchise, while raising the stakes in competition with Eli Lilly.

Nov 16
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Energy

Diamondback’s $5 Billion Permian Deal Puts US Shale Consolidation Back in the Spotlight

Diamondback Energy’s $5 billion Permian acquisition from Double Eagle highlights consolidation, acreage valuations and c…

Nov 16, 2026
Pharmaceutical

CG Oncology Stock Rises on Positive Phase 3 Bladder Cancer Results

CG Oncology shares moved higher after positive topline Phase 3 data for cretostimogene, with full PIVOT-006 results due …

Nov 16, 2026
Pharmaceutical

Summit Therapeutics Stock Plunges After FDA Rejects Lung Cancer Drug Application

Summit Therapeutics shares fell more than 19% in premarket trading after the FDA issued a Complete Response Letter for i…

Nov 16, 2026
Pharmaceutical

MiNK Therapeutics’ Phase 2 Lung-Injury Trial Sets Up FDA Design Catalyst

MiNK Therapeutics’ randomized Phase 2 trial of agenT-797 could gain strategic clarity through a planned FDA discussion b…

Nov 15, 2026
Pharmaceutical

Stoke Therapeutics Builds Commercial Infrastructure as Clinical Catalysts Approach

Stoke Therapeutics is expanding market-access teams while two data readouts approach, but preparation is not proof of ap…

Nov 15, 2026
Pharmaceutical

Cocrystal Pharma’s Widening Loss Meets Fresh OPKO Backing and Norovirus Trial Progress

Nasdaq-listed COCP reported a wider $3.44 million quarterly loss alongside Phase 1b progress and a $5 million OPKO inves…

Nov 15, 2026
Markets & Money

Norfolk Southern–Union Pacific Deal Spread Widens as CEO Remarks Stir Uncertainty

The widening spread between Norfolk Southern and Union Pacific puts deal timing and regulatory approval risk back in foc…

Nov 14, 2026
Markets & Money

FTC Threat to Block $3.5 Billion Covetrus-MWI Deal Raises Stakes for M&A Traders

A reported FTC lawsuit over the $3.5 billion Covetrus-MWI deal highlights regulatory risk for merger arbitrage and healt…

Nov 14, 2026
Pharmaceutical

Viking Therapeutics Takeover Chatter Puts VKTX Back in the M&A Spotlight

Renewed takeover interest lifted VKTX shares, sharpening the debate over obesity-drug consolidation and the risks of M&A…

Nov 14, 2026